Finding his voice
Mason arrived 13 weeks early. At just two pounds, he was taken to OHSU Doernbecher's NICU — and the specialized care he received made all the difference.Full Article
Bringing visibility to a rare disease
Nevaeh was diagnosed with Alport Syndrome, a rare genetic disorder that causes kidney disease. Hear from Nevaeh about her experience at Doernbecher and her hopes for the future.
Here for you
This holiday season, we celebrate you and the spirit of giving that makes a difference in people’s lives. We’ve gathered a few of the heartwarming, inspiring stories this past year made possible b...
Four questions with Shivaani Kummar, MD, FACP
Dr. Kummar's work is dedicated to early phase clinical trials — discovering new therapies for cancer and giving more people access to safe, experimental cancer treatments.
Four questions with Mark Pennesi, MD, PhD
Dr. Pennesi led the first-ever CRISPR gene-editing procedure within the human body, which is showing promising results. We asked him four questions about his research and what this breakthrough could ...
Where courage meets care
Penelope was born with a rare blood disorder. When complication after complication hit, her family turned to OHSU Doernbecher Children’s Hospital, who helped her family through a complex diagnosis.
Getting to know Jill Eiland
Jill Eiland was recently named interim president to lead the OHSU Foundation. Get to know Jill, in her own words, and what she's looking forward to as she leads the Foundation through this transition.